California Public Employees Retirement System Satsuma Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$4.8 - $7.25 $93,120 - $140,650
-19,400 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$3.56 - $5.09 $6,194 - $8,856
-1,740 Reduced 8.23%
19,400 $89,000
Q3 2020

Nov 05, 2020
BUY
$3.85 - $28.47 $3,080 - $22,776
800 Added 3.93%
21,140 $82,000
Q2 2020

Aug 12, 2020
BUY
$16.01 - $34.69 $325,643 - $705,594
20,340 New
20,340 $585,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email